Caroline Gaudy
Overview
Explore the profile of Caroline Gaudy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
279
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rossignol J, Ouedrani A, Livideanu C, Barete S, Terriou L, Launay D, et al.
J Allergy Clin Immunol Pract
. 2022 Jan;
10(5):1356-1364.e2.
PMID: 35074600
Background: Mast cells are key players in innate immunity and the T2 adaptive immune response. The latter counterbalances the T1 response, which is critical for antiviral immunity. Clonal mast cell...
2.
Stein C, Burtey S, Mancini J, Pelletier M, Sallee M, Brunet P, et al.
Nephrol Dial Transplant
. 2020 Sep;
36(9):1664-1674.
PMID: 32941608
Background: Immune checkpoints inhibitors have transformed the prognosis of advanced melanoma but are associated with immune-related adverse events (irAEs). We evaluated the incidence, risk factors and causes of acute kidney...
3.
Andriamanampisoa C, Bancaud A, Boutonnet-Rodat A, Didelot A, Fabre J, Fina F, et al.
Anal Chem
. 2018 Mar;
90(6):3766-3774.
PMID: 29498256
We describe a technology to perform sizing and concentration analysis of double stranded DNA with a sensitivity of 10 fg/μL in an operating time of 20 min. The technology is...
4.
Macagno N, Etchevers H, Malissen N, Rome A, Hesse S, Mallet S, et al.
Am J Surg Pathol
. 2018 Jan;
42(5):701-704.
PMID: 29369061
No abstract available.
5.
Cook M, Massi D, Blokx W, van den Oord J, Koljenovic S, De Giorgi V, et al.
Histopathology
. 2017 Jul;
71(6):943-950.
PMID: 28741688
Aims: Because the term 'naevoid melanoma' has variable clinical and pathological interpretations, we aimed to clarify the features of melanomas referred to as naevoid. Methods And Results: A review was...
6.
Gaudy C, Clevy C, Monestier S, Dubois N, Preau Y, Mallet S, et al.
Diabetes Care
. 2015 Aug;
38(11):e182-3.
PMID: 26310693
No abstract available.
7.
Albarel F, Gaudy C, Castinetti F, Carre T, Morange I, Conte-Devolx B, et al.
Eur J Endocrinol
. 2014 Nov;
172(2):195-204.
PMID: 25416723
Objective: Few data are published on the long-term follow-up of ipilimumab-induced hypophysitis, a cytotoxic T-lymphocyte antigen 4 antibody. We characterized hypophysitis in terms of clinical signs, endocrinological profile, and imaging...
8.
Cachin F, Miot-Noirault E, Gillet B, Isnardi V, Labeille B, Payoux P, et al.
J Nucl Med
. 2013 Nov;
55(1):15-22.
PMID: 24263087
Unlabelled: Our group has developed a new radiopharmaceutical, (123)I - N-(2-diethylaminoethyl)-2-iodobenzamide ((123)I-BZA2), a benzamide derivative able to bind to melanin pigment in melanoma cells. In a prospective and multicentric phase...
9.
Grob J, Gaudy C
Rev Prat
. 2007 Nov;
57(13):1397-400.
PMID: 18018536
Mortality by melanoma has not decreased, despite intensive medical screening, multiple campaigns based on ABCD, and a more efficacious surveillance of people at risk by dermatologists. We thus have to...
10.
Nicol I, Gaudy C, Gouvernet J, Richard M, Grob J
J Invest Dermatol
. 2006 Oct;
127(1):41-8.
PMID: 17068486
Whatever the improvement in the protection spectrum of sunscreens (SCs), actual skin protection mainly depends on the way they are used, especially on the quantity applied. This prospective randomized study...